Funding
← Back to your selection

LDV Partners

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$40M
1 disclosed · full round size, not this investor’s share

By stage

Growth1
Series B1

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
Primrose Bio

Primrose Bio supplies manufacturing technologies for biologic drugs, mRNA products and vaccines.

UndisclosedGrowth financing
Participant
Spot Biosystems

Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines

$40MSeries B
Role not disclosed